Ankyrin repeat domain 33B pseudogene 3 (ANKRD33BP3)

ANKRD33BP3 refers to a pseudogene and not a protein-coding gene or canonical molecular target. By definition, pseudogenes are genomic DNA sequences similar to known genes but generally noncoding and often considered nonfunctional[2]. However, some pseudogenes are transcribed or exert regulatory effects, for example acting as competing endogenous RNAs or serving as miRNA sponges, or influencing epigenetic regulation. There is no specific evidence that ANKRD33BP3 codes for a functional protein or acts as a typical therapeutic target (such as a receptor, enzyme, or transporter). As a pseudogene, ANKRD33BP3's biological and clinical relevance has not been established, and it is not recognized as a druggable or actionable target. Note that the closely related gene ANKRD33B (ankyrin repeat domain 33B) is a protein-coding gene implicated in developmental programming and cancer progression but is distinct from this pseudogene[1]. Summary of special notes: - ANKRD33BP3 is not a validated molecular target and should not be considered a druggable or functional entity for therapeutic applications. - ANKRD33BP3 is a pseudogene and not a protein-coding gene[2]. - If you intended to inquire about the related protein-coding gene, refer to ANKRD33B instead[1].

Other names

ANKRD33BP3Ankyrin repeat domain 33B pseudogene 3

None known